V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260017078 | 260010135 | 1.88 | 95.2 | Palliative (P) | 2018-09-19 | 2018-09-23 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | 2 | N | 260016443 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260017079 | 260010137 | 1.82 | 80 | Curative (C) | 2017-11-29 | 2017-12-13 | CARBO + THIOTEPA + TOPOTECAN | N | N | 260016530 | CARBO + THIOTEPA + TOPOTECAN |
| 260017080 | 260010139 | 1.7 | 61.8 | Curative (C) | 2018-02-07 | 2018-03-30 | CHOP - 21 days | 2 | N | 260016778 | CHOP |
| 260017081 | 260014804 | 1.83 | 0 | Curative (C) | 2015-05-24 | 2015-05-24 | IFOSFAMIDE + PACLITAXEL | 2 | N | 260016927 | IPO |
| 260017082 | 260017107 | null | null | Disease modification (D) | 2017-04-05 | 2017-04-10 | NIVOLUMAB | 02 | null | 260017081 | NIVOLUMAB |
| 260017083 | 260010144 | 1.72 | 80.6 | Disease modification (D) | 2017-08-24 | 2017-08-30 | IVE | 02 | N | 260017753 | PAC-PLAT |
| 260017084 | 260010145 | 1.77 | null | Curative (C) | 2015-04-24 | 2015-05-02 | GEMCITABINE + TIP | N | null | 260017849 | BLEOMYCIN + CARBOPLATIN + ETOPOSIDE |
| 260017085 | 260014807 | 1.84 | 89 | Palliative (P) | 2018-02-03 | 2018-02-03 | BLEOMYCIN | N | N | 260017935 | BENDAMUSTINE + OBINUTUZUMAB |
| 260017086 | 260014808 | 1.83 | 96 | Curative (C) | null | 2019-02-23 | CARBOPLATIN + ETOPOSIDE | N | null | 260017955 | VINCRISTINE |
| 260017087 | 260010153 | 1.76 | 77 | Palliative (P) | 2015-06-06 | 2015-06-06 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | 2 | N | 260018350 | BLEOMYCIN |
| 260017088 | 260010155 | 1.76 | 90.9 | Curative (C) | 2018-08-26 | 2018-09-06 | Bleomycin + Cisplatin + Vinblastine | 02 | null | 260018409 | CISPLATIN + DACTINOMYCIN + ETOPOSIDE + METHOTREXATE |
| 260017089 | 260010159 | null | 65.6 | Palliative (P) | 2017-01-12 | 2017-02-09 | NIVOLUMAB | N | N | 260018853 | IBRUTINIB |
| 260017090 | 260010163 | null | null | Disease modification (D) | null | 2017-09-28 | Cyclophosphamide PO +Vinorelbine IV | N | Y | 260019024 | ALEMTUZUMAB + CYCLO + FLUDARABINE |
| 260017091 | 260014811 | 1.68 | 95 | Palliative (P) | 2017-05-30 | 2017-05-30 | Carboplatin + Etoposide IV 3 day | N | null | 260019247 | ACE (GERM CELL) |
| 260017092 | 260010165 | 1.8 | 108.2 | Curative (C) | 2017-06-08 | 2017-06-09 | BLEOMYCIN + CISPLATIN + ETOPOSIDE + PACLITAXEL | 02 | N | 260019284 | BOP |
| 260017093 | 260010166 | 1.74 | 81 | Palliative (P) | 2019-03-18 | 2019-03-18 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | N | N | 260019465 | CISPLATIN + IFOSFAMIDE + PACLITAXEL |
| 260017094 | 260010171 | 1.59 | 51.4 | Neo-adjuvant (N) | 2016-06-03 | 2016-06-26 | Cisplatin + Radiotherapy | N | N | 260019645 | METHOTREXATE HIGH DOSE |
| 260017095 | 260010172 | 1.84 | 59.5 | Disease modification (D) | 2014-07-20 | 2014-07-20 | BLEOMYCIN + CISPLATIN + VINCRISTINE | 2 | N | 260019700 | BLEOMYCIN + VINCRISTINE |
| 260017096 | 260017114 | 1.82 | 79.8 | Disease modification (D) | 2013-11-30 | 2013-12-01 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | 02 | null | 260020079 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260017097 | 260010177 | 1.83 | 72.4 | Curative (C) | 2017-08-22 | 2017-08-24 | CYCLOPHOSPHAMIDE | 2 | N | 260020256 | BLEOMYCIN |
| 260017098 | 260010178 | 1.87 | 87.1 | null | 2017-08-09 | 2017-08-15 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE + PACLITAXEL | N | N | 260020285 | ICE |
| 260017099 | 260010181 | 1.8 | 68.6 | Disease modification (D) | 2017-05-21 | 2017-05-21 | PEMBROLIZUMAB | N | N | 260021538 | DOXORUBICIN |
| 260017100 | 260010182 | 1.72 | null | Adjuvant (A) | 2016-03-25 | 2016-03-28 | IVADo | N | N | 260021633 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 260017101 | 260010189 | 1.81 | 76.4 | Palliative (P) | 2019-08-15 | 2019-08-17 | Carboplatin + Etoposide IV 3 day | 2 | N | 260021774 | BLEOMYCIN |
| 260017102 | 260010191 | 1.56 | 107.9 | Adjuvant (A) | 2017-01-10 | 2017-03-13 | CHOP - 21 days | N | N | 260022492 | ICE |
| 260017103 | 260014823 | null | null | Curative (C) | 2016-05-04 | 2016-05-04 | ICE + GCSF | 02 | N | 260022515 | CARBOPLATIN + ETOPOSIDE |
| 260017104 | 260014824 | 1.78 | 80.4 | Curative (C) | 2017-06-20 | 2018-03-18 | Cisplatin + Vinorelbine (IV) | N | N | 260023349 | CISPLATIN + EPIRUBICIN |
| 260017105 | 260014824 | 1.72 | 96.35 | Palliative (P) | 2016-08-11 | 2016-08-24 | IPO | N | N | 260023349 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 260017106 | 260010196 | 1.85 | 97 | Disease modification (D) | 2018-04-06 | 2018-04-06 | BLEOMYCIN + VINCRISTINE | 2 | N | 260025486 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260017107 | 260010198 | null | 82.4 | Palliative (P) | 2016-11-07 | 2017-02-01 | Cisplatin | N | N | 260025887 | VINBLASTINE |
| 260017108 | 260010199 | 1.68 | 56.6 | Palliative (P) | 2018-11-19 | 2018-11-19 | CYCLOPHOSPHAMIDE + FLUDARABINE | 02 | N | 260026217 | DOCETAXEL + TRASTUZUMAB |
| 260017109 | 260010200 | 1.77 | 67.4 | Palliative (P) | 2016-04-07 | 2016-04-07 | CARBOPLATIN + ETOPOSIDE | N | N | 260026625 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260017110 | 260010200 | 177 | 66 | Curative (C) | 2016-02-07 | 2016-02-07 | IPO | 02 | N | 260026625 | PAC-E |
| 260017111 | 260010203 | 1.67 | 89.7 | Neo-adjuvant (N) | 2018-12-27 | 2018-12-27 | DOCETAXEL + TRASTUZUMAB | 2 | N | 260028496 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 260017112 | 260014829 | 1.71 | 101 | Curative (C) | 2016-06-16 | 2016-06-22 | STS Rhabdomyosarcoma RMS 2005 IVA | N | N | 260029516 | ACE (GERM CELL) |
| 260017113 | 260014830 | 1.57 | 75.6 | Curative (C) | 2018-08-13 | 2018-09-05 | Doxorubicin + Olaratumab | N | N | 260029639 | ESHAP R |
| 260017114 | 260010210 | 1.68 | 117 | Palliative (P) | 2016-08-03 | 2016-08-03 | BLEOMYCIN + VINCRISTINE | 2 | N | 260029897 | DOCETAXEL + TRASTUZUMAB |
| 260017115 | 260014832 | 1.6 | 78 | Curative (C) | 2019-09-21 | 2019-09-21 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | 02 | N | 260000136 | BLEOMYCIN + CISPLATIN + ETOPOSIDE |
| 260017116 | 260010215 | 1.72 | 81 | Curative (C) | null | 2019-01-05 | IFOSFAMIDE + PACLITAXEL | N | N | 260003454 | GEMCITABINE |
| 260017117 | 260010217 | 1.7 | 55.3 | Curative (C) | 2016-11-30 | 2016-11-30 | GEMCITABINE + TIP | N | N | 260006100 | BLEOMYCIN + CISPLATIN + ETOPOSIDE + PACLITAXEL |
| 260017118 | 260010222 | 1.63 | null | null | 2019-03-23 | 2019-03-25 | TRASTUZUMAB | N | N | 260007145 | FEC |
| 260017119 | 260010225 | 1.67 | 78.6 | Palliative (P) | 2017-08-16 | 2017-08-22 | Docetaxel 100mg/m2 (21 day) | 02 | N | 260007252 | TRASTUZUMAB |
| 260017120 | 260010227 | 1.58 | 61 | Curative (C) | 2016-02-13 | 2016-02-14 | CISPLATIN + GEMCITABINE + RITUXIMAB | N | N | 260007814 | CHOP |
| 260017121 | 260010230 | 1.84 | 65.3 | Curative (C) | 2018-04-30 | 2018-05-06 | IPO | 2 | N | 260008957 | CARBOPLATIN + RT |
| 260017122 | 260010231 | 1.73 | 80 | Curative (C) | 2018-10-06 | 2018-10-09 | IPO | 02 | N | 260009956 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 260017123 | 260010235 | 1.72 | 94.6 | Palliative (P) | 2017-07-22 | 2017-11-09 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | N | 260013467 | ACE (GERM CELL) |
| 260017124 | 260010236 | 1.5 | 46.6 | Curative (C) | 2017-01-13 | 2017-01-21 | Carboplatin 21day + Paclitaxel 7day | N | null | 260014181 | CHOP |
| 260017125 | 260014846 | 1.72 | 84 | null | null | 2017-04-18 | Bleomycin + Cisplatin + Vinblastine | null | null | 260015436 | DOXORUBICIN + OLARATUMAB |
| 260017126 | 260010239 | 1.62 | 53.2 | Palliative (P) | 2018-03-06 | 2018-10-02 | METHOTREXATE | N | N | 260017408 | DOCETAXEL + TRASTUZUMAB |
| 260017127 | 260010240 | 1.7 | 80.6 | Curative (C) | 2018-06-16 | 2018-09-06 | Methotrexate High Dose (3g/m2) | N | null | 260018978 | BENDAMUSTINE + OBINUTUZUMAB |